TCT 2009 schedule

Revision as of 14:03, 21 August 2009 by Apalmer (talk | contribs) (→‎8:30 AM)
Jump to navigation Jump to search

Here is the page we will use to coordinate the TV events at TCT 2009.



Click on Date for Detailed Schedule

Monday September 21, 2009

Tuesday September 22, 2009

Wednesday September 23, 2009

Thursday September 24, 2009

Friday September 25, 2009


Monday September 21, 2009

1:05 PM

1:05 PM - 1:15 PM

  • Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
  • Room: 104

1:51 PM

1:51 PM - 2:03 PM

  • Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
  • Room: 104

Return to top

Tuesday September 22, 2009

10:00 AM

10:00 AM - 12:00 PM

  • Event: Oral Abstracts- AMI
  • Room: 125

12:30 PM

12:30 PM - 1:00 PM

  • Event: Interview
  • Room: East 264
  • Interviewee: Pieter C. Smits
  • Confirmed: Yes
  • Trial: COMPARE. A Prospective, Randomized Trial of Everolimus-eluting vs. Paclitaxel-Eluting Stents
  • Phone number:

1:00 PM

1:00 PM - 1:30 PM

  • Event: Interview
  • Room: East 264
  • Interviewee: Shamir Mehta
  • Confirmed: Yes
  • Trial: CURRENT-PCI OASIS 7. A Prospective, Randomized, Placebo-Controlled Trial of high vs. Standard Dose Clopidogrel and High vs. Low Dose Aspirin in Patients Undergoing PCI for ACS
  • Phone number:


Return to top

Wednesday September 23, 2009

8:30 AM

8:30 AM - 9:00 AM

  • Event: Interview
  • Room: East 264
  • Interviewee: William Fearon
  • Confirmed: Yes
  • Trial: FAME: 2-Year Follow-up From a Prospective, Randomized Trial of FFR-Guided vs. Angiography-Guided PCI in Patients with Multivessel Coronary Artery Disease
  • Phone number:

9:00 AM

9:00 AM - 9:30 AM

  • Event: Interview
  • Room: East 264
  • Interviewee: Lorenz Raber
  • Confirmed: Yes
  • Trial: SIRTAX-LATE. 5-Year Clinical and Angiographic Follow-up from a Prospective, Randomized Trial of Sirolimus-Eluting and Paclitaxel-Eluting Stents Normal 0 false false false MicrosoftInternetExplorer4
    Normal   0         false   false   false                             MicrosoftInternetExplorer4        *Phone number:

9:30 AM

9:30 AM - 10:00 AM

  • Event: Interview
  • Room: East 264
  • Interviewee: Volker Klauss
  • Confirmed: Yes
  • Trial: LEADERS. 2-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-Edulting Stents with a Bioabsorbable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer
  • Phone number:
    Normal   0         false   false   false                             MicrosoftInternetExplorer4        
    Normal   0         false   false   false                             MicrosoftInternetExplorer4        ===10:00 AM===

10:00 AM - 10:30 AM

  • Event: Interview
  • Room: East 264
  • Interviewee: Deepak Bhatt
  • Confirmed: Yes
  • Trial: COGENT. A Prospective, Randomized, Placebo-Controlled Trial of Omeprazole in Patients Receiving Aspirin and Clopidogrel
    Normal   0         false   false   false                             MicrosoftInternetExplorer4        *Phone number:

10:30 AM

10:30 AM - 11:00 AM

  • Event: Interview
  • Room: East 264
  • Interviewee: David Cohen
  • Confirmed: Yes
  • Trial: TRITON-TIMI 38 ECONOMIC SUBSTUDY. Cost-Effectiveness of Prasugrel vs. Clopidogrel From a Prospective, Randomized Trial of Patients with ACS Undergoing PCI
    Normal   0         false   false   false                             MicrosoftInternetExplorer4        *Phone number:

11:00 AM

11:00 AM - 11:30 AM

  • Event: Interview
  • Room: East 264
  • Interviewee: Chris Cannon
  • Confirmed: Yes
  • Trial: PLATO INVASIVE. A Prospective, Randomized, Placebo-Controlled Trial of Ticagrelor vs. Clopidogrel in Patients with ACS Managed with an Invasive Strategy
  • Phone number:

12:00 PM

12:00 PM - 12:30 PM

  • Event: Interview
  • Room: East 264
  • Interviewee: Robert Byrne
  • Confirmed: Yes
  • Trial: ISAR-DESIRE 2. A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents for Treatment of Restenosis in Sirolimus-Eluting Stents
  • Phone number: Normal 0 false false false MicrosoftInternetExplorer4
    Normal   0         false   false   false                             MicrosoftInternetExplorer4        
    Normal   0         false   false   false                             MicrosoftInternetExplorer4        ===12:45 PM===

12:45 PM - 12:50 PM

  • Event: Open Issues I: Adjunct Pharmacology. Schedule
  • Room: 130

1:35 PM

1:35 PM - 1:45 PM

  • Event: Open Issues I: Adjunct Pharmacology. Schedule
  • Room: 130

4:00 PM

4:00 PM - 4:45 PM

  • Event: Main Arena I. Plenary Session #7 Personalized Clinical Decision-Making Case Study: The Ischemia vs. Bleeding Controversy
  • Room: Esplanade Ballroom

Return to top

Thursday September 24, 2009

8:46 AM

8:46 AM - 11:11 AM

  • Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 2: Current Choices in Antithrombin Therapy for ACS and PCI
  • Room: 135

11:45 PM

11:45 AM - 11:57 AM

  • Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
  • Room: 135

12:09 PM

12:09 PM - 12:24 PM

  • Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
  • Room: 135

5:02 PM

5:02 PM - 5:14 PM

  • Event: Balancing Safety and Efficacy of Antithrombotic Therapies for PCI and ACS. Antiplatelet Agents, Bleeding, and Ischemia
  • Room: 135

Return to top

Friday September 25, 2009

2:24 PM

2:24 PM - 2:36 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

GPIIb/IIIa Inhibitors in ACS: EARLY ACS

  • Room: EBM and Guidelines Theater, Hall D

2:36 PM

2:36 PM - 3:12 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

Aspirin and Clopiodgrel in ACS: CURRENT-OASIS 7

  • Room: EBM and Guidelines Theater, Hall D

3:00 PM

3:00 PM - 3:12 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

Aspirin and Clopiodgrel in ACS: CURRENT-OASIS 7

  • Room: EBM and Guidelines Theater, Hall D

3:24 PM

3:24 PM - 3:36 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

Ticagrelor in ACS: PLATO

  • Room: EBM and Guidelines Theater, Hall D

3:36 PM

3:36 PM - 3:48 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

Ticagrelor in ACS: PLATO

  • Room: EBM and Guidelines Theater, Hall D

Return to top